miRNA arrays

Using array-based miRNA profiles for individuals treated for prostate cancer, researchers identified 37 miRNA with differential expression in cases with recurrence.

NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.

The proof-of-principle application suggests networks of microRNA, RNA, and other 'omics data can untangle drug response and more.

NEW YORK (GenomeWeb) — Researchers interested in microRNA expression profiling today face a bevy of options including microarrays, quantitative PCR assays, and next-generation sequencing applications, but it is not always obvious which platform is the most suitable for a given study.

Exiqon continues to see demand for its microRNA microarray products, though its quantitative PCR assays and functional analysis products are driving its sales, according to its CEO Lars Kongsbak.

NEW YORK (GenomeWeb News) – A Medicare contractor has issued a final coverage determination confirming coverage for one of Rosetta Genomics' microRNA-based cancer diagnostics, but denying Medicare coverage for two of the firm's other tests, Rosetta announced today.

Rosetta Genomics has published a study describing the development and initial validation of its miRview Kidney test, a 24-microRNA array-based assay that classifies a patient's primary kidney tumor into one of four main subtypes.

With a handful of recently awarded grants, startup Circulomics is kicking off development of its technology as a tool for lower cost and more accessible multiplex analysis of disease-associated microRNAs, and is planning to launch its first kit, a 30-plex, semi-customizable cance

Affymetrix's latest offering to researchers studying microRNA continues to stand alone in the marketplace.

Three microRNAs have been implicated in the transformation of normal fibroblasts into cancer-promoting cells and could be potential drug targets in ovarian cancer, a study by University of Chicago and Northwestern University researchers has suggested.

Pages

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.